Actelion CEO dismisses talk of Basilea buyout bid

Nick Paul Taylor

CEO Jean-Paul Clozel has dismissed the possibility of making a bid to buy Pharmaceutica. The comment quashed speculation that and Basilea could find solutions to their respective challenges by merging.

 

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS